For more than 20 years, Biogaran has been innovating and developing itself to provide you with services and therapeutic solutions that answer your needs.
Discover our history.
Biogaran, reinventing itself since 1996
1996 Foundation of Biogaran, a pioneer in generic drugs
1998 Launch of a new and innovative packaging
2004 First generic contraceptive pill
2005 First international development
2006 First communication campaign
2011 Launch of the over-the-counter drug range of drugs
2015 Launch of the first biosimilar drug
2017 First export of Biogaran products to Lebanon
2018 New visual identity for the line Biogaran Conseil®
Our international development
- Near and Middle East
- Latin America
- 2005 Launch of business activities in Paraguay
- 2017 Launch of business activities in Lebanon
- 2019 Launch of business activities in Ivory coast, Gabon and Congo
- 2020 Launch of business activities in Senegal, Mali and Guinea
- 2021 Launch of business activities in Benin, Niger, Malta, Madagascar, Mauritius and countries of the Near and Middle East
- 2022 Beginning of our operations in the DRC, in Mauritania and in Iraq
The development of our activities in the Near and Middle East
It is with the goal of offering quality medicines that meet the strictest European standards that Biogaran began the deployment of its activities in the Near and Middle East in 2017 with the launch of its commercial activities in Lebanon. In order to meet the challenges of public health and to provide quality medicines adapted to the needs of patients, Biogaran wishes to continue to develop its activities in the region in the coming years, particularly in Iraq, where Biogaran will launch its activities in 2022.
Thanks to bioequivalent quality medicines complying with the most stringent European standards, Biogaran's ambition is to become the first choice for patients who wish to have access to high-quality generic drugs and that they will be able to use safely.